1 | kowa pharmaceuticals america inc | | | | | | | 7 | 0.18% |
2 | use of the site | | | | | | | 6 | 0.15% |
3 | a registered trademark of | | | | | | | 4 | 0.10% |
4 | is a registered trademark | | | | | | | 4 | 0.10% |
5 | contained on the site | | | | | | | 4 | 0.10% |
6 | any use of the | | | | | | | 3 | 0.08% |
7 | have been reported with | | | | | | | 3 | 0.08% |
8 | data safety in clinical | | | | | | | 3 | 0.08% |
9 | trial data safety in | | | | | | | 3 | 0.08% |
10 | clinical trial data safety | | | | | | | 3 | 0.08% |
11 | the information contained on | | | | | | | 3 | 0.08% |
12 | statins adult patient types | | | | | | | 3 | 0.08% |
13 | adult patient types metabolism | | | | | | | 3 | 0.08% |
14 | information contained on the | | | | | | | 3 | 0.08% |
15 | we may disclose information | | | | | | | 3 | 0.08% |
16 | of the united states | | | | | | | 3 | 0.08% |
17 | from time to time | | | | | | | 3 | 0.08% |
18 | of the site or | | | | | | | 3 | 0.08% |
19 | safety in clinical trials | | | | | | | 3 | 0.08% |
20 | your use of the | | | | | | | 2 | 0.05% |
21 | commercial use of the | | | | | | | 2 | 0.05% |
22 | on the site is | | | | | | | 2 | 0.05% |
23 | pharmaceuticals america inc shall | | | | | | | 2 | 0.05% |
24 | to notify the user | | | | | | | 2 | 0.05% |
25 | the site is for | | | | | | | 2 | 0.05% |
26 | the site may contain | | | | | | | 2 | 0.05% |
27 | so the above exclusion | | | | | | | 2 | 0.05% |
28 | cookies on your device | | | | | | | 2 | 0.05% |
29 | shall be free to | | | | | | | 2 | 0.05% |
30 | using this site you | | | | | | | 2 | 0.05% |
31 | by using this site | | | | | | | 2 | 0.05% |
32 | or in connection with | | | | | | | 2 | 0.05% |
33 | including but not limited | | | | | | | 2 | 0.05% |
34 | but not limited to | | | | | | | 2 | 0.05% |
35 | from any and all | | | | | | | 2 | 0.05% |
36 | site is subject to | | | | | | | 2 | 0.05% |
37 | indications and usage livalo | | | | | | | 2 | 0.05% |
38 | officers employees and agents | | | | | | | 2 | 0.05% |
39 | kowa unless otherwise stated | | | | | | | 2 | 0.05% |
40 | this site is intended | | | | | | | 2 | 0.05% |